Skip to main content

Advertisement

SpringerLink
Log in

Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity

  • Original Investigation
  • Published:
Medical Microbiology and Immunology Aims and scope Submit manuscript

Abstract

We try to find the association of cytomegalovirus (CMV) infection and anti-β2 glycoprotein 1 autoantibodies (anti-β2 GP1), a key antibody in antiphospholipid syndrome (APS), among systemic lupus erythematosus (SLE) and cerebral vascular accident (CVA) patients. This retrospective study enrolled serum samples obtained from 87 SLE and 97 CVA patients who have been checked for the existence of anti-β2 GP1. First, the prevalence rate of anti-CMV IgG and IgM in patients with and without anti-β2 GP1 were compared. Second, the prevalence of anti-CMV IgG and IgM were compared between SLE and CVA patients. Last, this study analyzed the clinical characteristics and disease activity in SLE patients with positive anti-CMV IgM and IgG. No difference existed in the prevalence rate of anti-CMV IgG and IgM between positive or negative anti-β2 GP1 serum samples in both SLE and CVA patients. However, the prevalence of anti-CMV IgM was significantly higher in the SLE group than in the CVA group. Severity of clinical features and SLEDAI scores were considerably higher in patients with positive anti-CMV IgM than in SLE patients with negative anti-CMV IgM. Very impressively, all IgM-positive SLE samples (9/9) carrying highest levels of anti-CMV IgG, indicated reactivation of the latent CMV infection. Hence, it suggests that CMV reactivation might contribute toward the disease flare in some SLE patients. In future, a prospective and longitudinal study is stongly indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GR (2001) Systemic lupus erythematosus. Lancet 357:1027–1032

    Article  PubMed  CAS  Google Scholar 

  2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306

    Article  PubMed  CAS  Google Scholar 

  3. Gharavi AE, Pierangeli SS, Harris EN (2003) Viral origin of antiphospholipid antibodies: endothelial cell activation and thrombus enhancement by CMV peptide-induced APL antibodies. Immunobiology 207:37–42

    Article  PubMed  CAS  Google Scholar 

  4. Blank M, Shoenfeld Y (2004) Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Clin Immunol 112:190–199

    Article  PubMed  CAS  Google Scholar 

  5. Blank M, Asherson RA, Cervera R, Shoenfeld Y (2004) Antiphospholipid syndrome infectious origin. J Clin Immunol 24:12–23

    Article  PubMed  CAS  Google Scholar 

  6. Bakimer R, Blank M, Kosashvilli D, Ichikawa K, Khamashta MA, Hughes GR, Koike T, Shoenfeld Y (1995) Antiphospholipid syndrome and the idiotypic network. Lupus 4:204–208

    PubMed  CAS  Google Scholar 

  7. Ngou J, Graafland H, Segondy M (1992) Antibodies against polypeptides of purified Epstein-Barr virus in sera from patients with connective tissue diseases. J Autoimmun 5:243–249

    Article  PubMed  CAS  Google Scholar 

  8. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  PubMed  CAS  Google Scholar 

  9. Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288–291

    PubMed  Google Scholar 

  10. Nawata M, Seta N, Yamada M, Sekigawa I, Lida N, Hashimoto H (2001) Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus. Scand J Rheumatol 30:360–362

    Article  PubMed  CAS  Google Scholar 

  11. Sekigawa I, Nawata M, Seta N, Yamada M, Iida N, Hashimoto H (2002) Cytomegalovirus infection in patients with systemic lupus erythematosus. Clin Exp Rheumatol 20:559–564

    PubMed  CAS  Google Scholar 

  12. Bruggeman CA (1993) Cytomegalovirus and latency: an overview. Virchows Arch B Cell Pathol Incl Mol Pathol 64:325–333

    Article  PubMed  CAS  Google Scholar 

  13. Yoda Y, Hanaoka R, Ide H, Isozaki T, Matsunawa M, Yajima N, Shiozawa F, Miwa Y, Negishi M, Kasama T (2006) Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemia. Mod Rheumatol 16:137–142

    Article  PubMed  Google Scholar 

  14. Stratta P, Colla L, Santi S, Grill A, Besso L, Godio L, Davico-Bonino L, Mazzucco G, Ghisetti V, Barbui A, Canavese C (2002) IgM antibodies against cytomegalovirus in SLE nephritis: viral infection or aspecific autoantibody? J Nephrol 15:88–92

    PubMed  Google Scholar 

  15. Tardy JC, Bosshard S, Aymard M (1985) [Immunologic markers of the risk of cytomegalovirus infection among immunosuppressed patients]. Rev Epidemiol Sante Publique 33:297–303

    PubMed  CAS  Google Scholar 

  16. Temcharoen S, Hirsch P, Theamboonlers A, Likitnukul S, Seksarn P, Poovorawan Y (1999) Cytomegalovirus infection in immunocompromised children in Thailand. Asian Pac J Allergy Immunol 17:295–299

    PubMed  CAS  Google Scholar 

  17. Stratta P, Canavese C, Ciccone G, Santi S, Quaglia M, Ghisetti V, Marchiaro G, Barbui A, Fop F, Cavallo R, Piccoli G (1999) Correlation between cytomegalovirus infection and Raynaud’s phenomenon in lupus nephritis. Nephron 82:145–154

    Article  PubMed  CAS  Google Scholar 

  18. Hrycek A, Kusmierz D, Mazurek U, Wilczok T (2005) Human cytomegalovirus in patients with systemic lupus erythematosus. Autoimmunity 38:487–491

    Article  PubMed  Google Scholar 

  19. Hayashi T, Lee S, Ogasawara H, Sekigawa I, Iida N, Tomino Y, Hashimoto H, Hirose S (1998) Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. Lupus 7:561–564

    Article  PubMed  CAS  Google Scholar 

  20. Zhu J, Newkirk MM (1994) Viral induction of the human autoantigen calreticulin. Clin Invest Med 17:196–205

    PubMed  CAS  Google Scholar 

  21. Zhu J (1995) Cytomegalovirus infection induces expression of 60 KD/Ro antigen on human keratinocytes. Lupus 4:396–406

    PubMed  CAS  Google Scholar 

  22. Ikura Y, Matsuo T, Ogami M, Yamazaki S, Okamura M, Yoshikawa J, Ueda M (2000) Cytomegalovirus associated pancreatitis in a patient with systemic lupus erythematosus. J Rheumatol 27:2715–2717

    PubMed  CAS  Google Scholar 

  23. Vilaichone K, Mahachai V, Eiam-Ong S, Kullavanuaya P, Wisedopas N, Bhattarakosol P (2001) Necrotizing ileitis caused by cytomegalovirus in patient with systemic lupus erythematosus: case report. J Med Assoc Thai 84 (Suppl. 1):S469–S473

    PubMed  Google Scholar 

  24. Sakamoto O, Ando M, Yoshimatsu S, Kohrogi H, Suga M, Ando M (2002) Systemic lupus erythematosus complicated by cytomegalovirus-induced hemophagocytic syndrome and colitis. Intern Med 41:151–155

    PubMed  Google Scholar 

  25. Yoon KH, Fong KY, Tambyah PA (2002) Fatal cytomegalovirus infection in two patients with systemic lupus erythematosus undergoing intensive immunosuppressive therapy: role for cytomegalovirus vigilance and prophylaxis? J Clin Rheumatol 8:217–222

    Article  PubMed  Google Scholar 

  26. Scholz M, Doerr HW, Cinatl J (2003) Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence. Trends Microbiol 11:171–178

    Article  PubMed  CAS  Google Scholar 

  27. Akagi S, Ichikawa H, Suzuki J, Makino H (2004) Systemic lupus erythematosus associated with cytomegalovirus infection. Scand J Rheumatol 33:58–59

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Allergy, Immuology and Rheumatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University College of Medicine, No.123, Ta-Pei Road, Niao-Sung Hsiang, 833, Kaohsiung Hsein, Taiwan

    Ben Yu-Jih Su, Shan-Fu Yu & Chung-Jen Chen

  2. Department of Pathology, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung Hsein, Taiwan

    Cheng-Yu Su

Authors
  1. Ben Yu-Jih Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cheng-Yu Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shan-Fu Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chung-Jen Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chung-Jen Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Su, B.YJ., Su, CY., Yu, SF. et al. Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity. Med Microbiol Immunol 196, 165–170 (2007). https://doi.org/10.1007/s00430-007-0040-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00430-007-0040-7

Keywords

Search

Navigation